| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Vivo Capital, LLC
|
1.790m | 6.42% | — | Mar 31 2026 |
| 2 |
Millennium Management LLC
|
1.399m | 5.02% | +226.681k | Mar 31 2026 |
| 3 |
Octagon Capital Advisors LP
|
1.000m | 3.59% | — | Mar 31 2026 |
| 4 |
Nantahala Capital Management, LLC
|
939.202k | 3.37% | — | Mar 31 2026 |
| 5 |
Vanguard Capital Management, LLC
|
811.430k | 2.91% | +811.430k | Mar 31 2026 |
|
1
Vivo Capital, LLC
|
6.42%
1.790m
|
|
2
Millennium Management LLC
|
5.02%
1.399m
|
|
3
Octagon Capital Advisors LP
|
3.59%
1.000m
|
|
4
Nantahala Capital Management, LLC
|
3.37%
939.202k
|
|
5
Vanguard Capital Management, LLC
|
2.91%
811.430k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 21.32% of Unicycive Therapeutics Inc, with Vivo Capital, LLC the biggest at 6.42%, followed by Millennium Management LLC (5.02%) and Octagon Capital Advisors LP (3.59%). |
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Unicycive Therapeutics Inc has risen over the past 12 months from around 7.6% to 14.4% of the float. More and more market participants are betting on falling prices. That reflects growing skepticism, but also carries upside potential through a possible short squeeze. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


